 |
PDBsum entry 2ptk
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Tyrosine-protein kinase
|
PDB id
|
|
|
|
2ptk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
274:757-775
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
|
|
J.C.Williams,
A.Weijland,
S.Gonfloni,
A.Thompson,
S.A.Courtneidge,
G.Superti-Furga,
R.K.Wierenga.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Src protein tyrosine kinase plays a critical role in a variety of signal
transduction pathways. Strict regulation of its activity is necessary for proper
signalling. We present here the crystal structure of chicken Src which is
phosphorylated at Tyr527 and represents its least active form. Our structure,
similar to the recently reported human Hck and Src structures, contains the SH3,
SH2 and the kinase domains and the C-terminal regulatory tail but not the
N-terminal unique domain. The SH3 domain uses its hydrophobic surface to
coordinate the SH2-kinase linker such that residues Gln251 and Leu255
specifically interact with side chains in the beta2-beta3 and the alphaC-beta4
loops of the N-terminal lobe opposite of the kinase active site. This position
of the SH3 domain and the coordination of the SH2-kinase linker also optimally
places the SH2 domain such that the phosphorylated Tyr527 in the C-terminal tail
interacts with the SH2 binding pocket. Analogous to Cdk2 kinase, the position of
the Src alphaC-helix in the N-terminal lobe is swung out disrupting the position
of the active site residues. Superposition of other protein kinases including
human Hck and Src onto chicken Src indicate that the alphaC-helix position is
affected by the relative position of the N-terminal lobe with respect to the
C-terminal lobe of the kinase and that the presence of the SH3/SH2-kinase
linker/N-terminal lobe interactions restricts the kinase lobes and alphaC-helix
access to the active conformation. These superpositions also suggest that the
highly conserved alphaC-beta4 loop restricts the conformational freedom of the
N-terminal lobe by anchoring it to the C-terminal lobe. Finally, based on
sequence alignments and conservation of hydrophobic residues in the Src
SH2-kinase linker as well as in the alphaC-beta4 and beta2-beta3 loops, we
propose that the Src-related kinases, Abl, Btk and Csk, share the same
quaternary structure.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 6.
Figure 6. Superposition of chicken and human Src. The
colour code for the chicken Src residues is as in Figure 1; the
human Src residues are in dark blue. Top, Superposition of the
SH3 domain and the N-terminal lobe. Bottom, Superposition of the
C-terminal lobe.
|
 |
Figure 7.
Figure 7. Superposition of the N-terminal lobes of chicken
Src and human Hck. The colour code for the chicken Src residues
is as in Figure 1; the human Hck residues are in dark blue. For
chicken Src side-chains of the following residues are shown:
Arg95, Tyr90, Tyr136, Trp118 (SH3 domain), Leu255 (SH2-kinase
linker), and Trp286, Tyr326, and Gln324 (N-ter minal domain).
The equivalent residues of Hck are also shown.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1997,
274,
757-775)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.Yang,
N.Campobasso,
M.P.Biju,
K.Fisher,
X.Q.Pan,
J.Cottom,
S.Galbraith,
T.Ho,
H.Zhang,
X.Hong,
P.Ward,
G.Hofmann,
B.Siegfried,
F.Zappacosta,
Y.Washio,
P.Cao,
J.Qu,
S.Bertrand,
D.Y.Wang,
M.S.Head,
H.Li,
S.Moores,
Z.Lai,
K.Johanson,
G.Burton,
C.Erickson-Miller,
G.Simpson,
P.Tummino,
R.A.Copeland,
and
A.Oliff
(2011).
Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
|
| |
Chem Biol,
18,
177-186.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Dusa,
C.Mouton,
C.Pecquet,
M.Herman,
and
S.N.Constantinescu
(2010).
JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors.
|
| |
PLoS One,
5,
e11157.
|
 |
|
|
|
|
 |
E.Gringeri,
A.Carraro,
E.Tibaldi,
F.E.D'Amico,
M.Mancon,
A.Toninello,
M.A.Pagano,
C.Vio,
U.Cillo,
and
A.M.Brunati
(2010).
Lyn-mediated mitochondrial tyrosine phosphorylation is required to preserve mitochondrial integrity in early liver regeneration.
|
| |
Biochem J,
425,
401-412.
|
 |
|
|
|
|
 |
S.Gonfloni
(2010).
DNA damage stress response in germ cells: role of c-Abl and clinical implications.
|
| |
Oncogene,
29,
6193-6202.
|
 |
|
|
|
|
 |
Y.H.Hsu,
and
J.A.Traugh
(2010).
Reciprocally coupled residues crucial for protein kinase Pak2 activity calculated by statistical coupling analysis.
|
| |
PLoS One,
5,
e9455.
|
 |
|
|
|
|
 |
C.Brignatz,
M.P.Paronetto,
S.Opi,
M.Cappellari,
S.Audebert,
V.Feuillet,
G.Bismuth,
S.Roche,
S.T.Arold,
C.Sette,
and
Y.Collette
(2009).
Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn.
|
| |
Mol Cell Biol,
29,
6438-6448.
|
 |
|
|
|
|
 |
J.Zhao,
Y.Zhang,
S.S.Ithychanda,
Y.Tu,
K.Chen,
J.Qin,
and
C.Wu
(2009).
Migfilin interacts with Src and contributes to cell-matrix adhesion-mediated survival signaling.
|
| |
J Biol Chem,
284,
34308-34320.
|
 |
|
|
|
|
 |
K.Huang,
Y.H.Wang,
A.Brown,
and
G.Sun
(2009).
Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.
|
| |
J Mol Biol,
386,
1066-1077.
|
 |
|
|
|
|
 |
N.Yokoyama,
and
C.C.Malbon
(2009).
Dishevelled-2 docks and activates Src in a Wnt-dependent manner.
|
| |
J Cell Sci,
122,
4439-4451.
|
 |
|
|
|
|
 |
R.Barouch-Bentov,
J.Che,
C.C.Lee,
Y.Yang,
A.Herman,
Y.Jia,
A.Velentza,
J.Watson,
L.Sternberg,
S.Kim,
N.Ziaee,
A.Miller,
C.Jackson,
M.Fujimoto,
M.Young,
S.Batalov,
Y.Liu,
M.Warmuth,
T.Wiltshire,
M.P.Cooke,
and
K.Sauer
(2009).
A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function.
|
| |
Mol Cell,
33,
43-52.
|
 |
|
|
|
|
 |
R.E.Joseph,
and
A.H.Andreotti
(2009).
Conformational snapshots of Tec kinases during signaling.
|
| |
Immunol Rev,
228,
74-92.
|
 |
|
|
|
|
 |
D.E.Johnson
(2008).
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.
|
| |
Adv Enzyme Regul,
48,
98.
|
 |
|
|
|
|
 |
I.G.Muñoz,
F.J.Blanco,
and
G.Montoya
(2008).
On the relevance of defining protein structures in cancer research.
|
| |
Clin Transl Oncol,
10,
204-212.
|
 |
|
|
|
|
 |
L.Trentin,
M.Frasson,
A.Donella-Deana,
F.Frezzato,
M.A.Pagano,
E.Tibaldi,
C.Gattazzo,
R.Zambello,
G.Semenzato,
and
A.M.Brunati
(2008).
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia.
|
| |
Blood,
112,
4665-4674.
|
 |
|
|
|
|
 |
X.Xiong,
P.Cui,
S.Hossain,
R.Xu,
B.Warner,
X.Guo,
X.An,
A.K.Debnath,
D.Cowburn,
and
L.Kotula
(2008).
Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by phosphopeptides derived from Abi1/Hssh3bp1.
|
| |
Biochim Biophys Acta,
1783,
737-747.
|
 |
|
|
|
|
 |
A.E.Greenstein,
N.Echols,
T.N.Lombana,
D.S.King,
and
T.Alber
(2007).
Allosteric activation by dimerization of the PknD receptor Ser/Thr protein kinase from Mycobacterium tuberculosis.
|
| |
J Biol Chem,
282,
11427-11435.
|
 |
|
|
|
|
 |
A.J.Caplan,
A.K.Mandal,
and
M.A.Theodoraki
(2007).
Molecular chaperones and protein kinase quality control.
|
| |
Trends Cell Biol,
17,
87-92.
|
 |
|
|
|
|
 |
C.H.Yun,
T.J.Boggon,
Y.Li,
M.S.Woo,
H.Greulich,
M.Meyerson,
and
M.J.Eck
(2007).
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity.
|
| |
Cancer Cell,
11,
217-227.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Adolph,
N.Flach,
K.Mueller,
D.H.Ostareck,
and
A.Ostareck-Lederer
(2007).
Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.
|
| |
Mol Cell Biol,
27,
1758-1770.
|
 |
|
|
|
|
 |
J.Xu,
X.H.Bai,
M.Lodyga,
B.Han,
H.Xiao,
S.Keshavjee,
J.Hu,
H.Zhang,
B.B.Yang,
and
M.Liu
(2007).
XB130, a novel adaptor protein for signal transduction.
|
| |
J Biol Chem,
282,
16401-16412.
|
 |
|
|
|
|
 |
M.A.Seeliger,
B.Nagar,
F.Frank,
X.Cao,
M.N.Henderson,
and
J.Kuriyan
(2007).
c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.
|
| |
Structure,
15,
299-311.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Chen,
S.Brier,
T.E.Smithgall,
and
J.R.Engen
(2007).
The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
|
| |
Protein Sci,
16,
572-581.
|
 |
|
|
|
|
 |
D.T.Lodowski,
V.M.Tesmer,
J.L.Benovic,
and
J.J.Tesmer
(2006).
The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs.
|
| |
J Biol Chem,
281,
16785-16793.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Ozkirimli,
and
C.B.Post
(2006).
Src kinase activation: A switched electrostatic network.
|
| |
Protein Sci,
15,
1051-1062.
|
 |
|
|
|
|
 |
H.X.Zhou
(2006).
Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.
|
| |
Biophys J,
91,
3170-3181.
|
 |
|
|
|
|
 |
M.Chen,
S.C.Chen,
and
C.J.Pallen
(2006).
Integrin-induced tyrosine phosphorylation of protein-tyrosine phosphatase-alpha is required for cytoskeletal reorganization and cell migration.
|
| |
J Biol Chem,
281,
11972-11980.
|
 |
|
|
|
|
 |
R.P.Bhattacharyya,
A.Reményi,
B.J.Yeh,
and
W.A.Lim
(2006).
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.
|
| |
Annu Rev Biochem,
75,
655-680.
|
 |
|
|
|
|
 |
S.A.Lieser,
J.Shaffer,
and
J.A.Adams
(2006).
SRC tail phosphorylation is limited by structural changes in the regulatory tyrosine kinase Csk.
|
| |
J Biol Chem,
281,
38004-38012.
|
 |
|
|
|
|
 |
A.K.Padyana,
H.Qiu,
A.Roll-Mecak,
A.G.Hinnebusch,
and
S.K.Burley
(2005).
Structural basis for autoinhibition and mutational activation of eukaryotic initiation factor 2alpha protein kinase GCN2.
|
| |
J Biol Chem,
280,
29289-29299.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.C.Lerner,
R.P.Trible,
A.P.Schiavone,
J.M.Hochrein,
J.R.Engen,
and
T.E.Smithgall
(2005).
Activation of the Src family kinase Hck without SH3-linker release.
|
| |
J Biol Chem,
280,
40832-40837.
|
 |
|
|
|
|
 |
G.U.Gangenahalli,
V.K.Singh,
Y.K.Verma,
P.Gupta,
R.K.Sharma,
R.Chandra,
S.Gulati,
and
P.M.Luthra
(2005).
Three-dimensional structure prediction of the interaction of CD34 with the SH3 domain of Crk-L.
|
| |
Stem Cells Dev,
14,
470-477.
|
 |
|
|
|
|
 |
H.I.e.Kim,
and
S.T.Lee
(2005).
An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
|
| |
J Biol Chem,
280,
28973-28980.
|
 |
|
|
|
|
 |
J.Yang,
S.M.Roe,
M.J.Cliff,
M.A.Williams,
J.E.Ladbury,
P.T.Cohen,
and
D.Barford
(2005).
Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.
|
| |
EMBO J,
24,
1.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.J.Ball,
R.Kühne,
J.Schneider-Mergener,
and
H.Oschkinat
(2005).
Recognition of Proline-Rich Motifs by Protein-Protein-Interaction Domains.
|
| |
Angew Chem Int Ed Engl,
44,
2852-2869.
|
 |
|
|
|
|
 |
N.Yokoyama,
C.D.deBakker,
F.Zappacosta,
M.J.Huddleston,
R.S.Annan,
K.S.Ravichandran,
and
W.T.Miller
(2005).
Identification of tyrosine residues on ELMO1 that are phosphorylated by the Src-family kinase Hck.
|
| |
Biochemistry,
44,
8841-8849.
|
 |
|
|
|
|
 |
S.A.Lieser,
C.Shindler,
B.E.Aubol,
S.Lee,
G.Sun,
and
J.A.Adams
(2005).
Phosphoryl transfer step in the C-terminal Src kinase controls Src recognition.
|
| |
J Biol Chem,
280,
7769-7776.
|
 |
|
|
|
|
 |
S.W.Cowan-Jacob,
G.Fendrich,
P.W.Manley,
W.Jahnke,
D.Fabbro,
J.Liebetanz,
and
T.Meyer
(2005).
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
|
| |
Structure,
13,
861-871.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.K.Wong,
J.A.Knowles,
and
J.H.Morse
(2005).
Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
|
| |
Am J Respir Cell Mol Biol,
33,
438-446.
|
 |
|
|
|
|
 |
B.Han,
X.H.Bai,
M.Lodyga,
J.Xu,
B.B.Yang,
S.Keshavjee,
M.Post,
and
M.Liu
(2004).
Conversion of mechanical force into biochemical signaling.
|
| |
J Biol Chem,
279,
54793-54801.
|
 |
|
|
|
|
 |
O.Hantschel,
and
G.Superti-Furga
(2004).
Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
|
| |
Nat Rev Mol Cell Biol,
5,
33-44.
|
 |
|
|
|
|
 |
S.Yuzawa,
N.N.Suzuki,
Y.Fujioka,
K.Ogura,
H.Sumimoto,
and
F.Inagaki
(2004).
A molecular mechanism for autoinhibition of the tandem SH3 domains of p47phox, the regulatory subunit of the phagocyte NADPH oxidase.
|
| |
Genes Cells,
9,
443-456.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Nagar,
O.Hantschel,
M.A.Young,
K.Scheffzek,
D.Veach,
W.Bornmann,
B.Clarkson,
G.Superti-Furga,
and
J.Kuriyan
(2003).
Structural basis for the autoinhibition of c-Abl tyrosine kinase.
|
| |
Cell,
112,
859-871.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.Hantschel,
B.Nagar,
S.Guettler,
J.Kretzschmar,
K.Dorey,
J.Kuriyan,
and
G.Superti-Furga
(2003).
A myristoyl/phosphotyrosine switch regulates c-Abl.
|
| |
Cell,
112,
845-857.
|
 |
|
|
|
|
 |
S.C.Harrison
(2003).
Variation on an Src-like theme.
|
| |
Cell,
112,
737-740.
|
 |
|
|
|
|
 |
A.T.Miller,
and
L.J.Berg
(2002).
New insights into the regulation and functions of Tec family tyrosine kinases in the immune system.
|
| |
Curr Opin Immunol,
14,
331-340.
|
 |
|
|
|
|
 |
B.E.Aubol,
B.Nolen,
D.Vu,
G.Ghosh,
and
J.A.Adams
(2002).
Mechanistic insights into Sky1p, a yeast homologue of the mammalian SR protein kinases.
|
| |
Biochemistry,
41,
10002-10009.
|
 |
|
|
|
|
 |
E.C.Lerner,
and
T.E.Smithgall
(2002).
SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
|
| |
Nat Struct Biol,
9,
365-369.
|
 |
|
|
|
|
 |
H.Qiu,
and
W.T.Miller
(2002).
Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
|
| |
J Biol Chem,
277,
34634-34641.
|
 |
|
|
|
|
 |
K.A.Gallo,
and
G.L.Johnson
(2002).
Mixed-lineage kinase control of JNK and p38 MAPK pathways.
|
| |
Nat Rev Mol Cell Biol,
3,
663-672.
|
 |
|
|
|
|
 |
K.Schweimer,
S.Hoffmann,
F.Bauer,
U.Friedrich,
C.Kardinal,
S.M.Feller,
B.Biesinger,
and
H.Sticht
(2002).
Structural investigation of the binding of a herpesviral protein to the SH3 domain of tyrosine kinase Lck.
|
| |
Biochemistry,
41,
5120-5130.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.W.Donaldson,
G.Gish,
T.Pawson,
L.E.Kay,
and
J.D.Forman-Kay
(2002).
Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
|
| |
Proc Natl Acad Sci U S A,
99,
14053-14058.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.P.Okoh,
and
M.Vihinen
(2002).
Interaction between Btk TH and SH3 domain.
|
| |
Biopolymers,
63,
325-334.
|
 |
|
|
|
|
 |
M.P.Scott,
F.Zappacosta,
E.Y.Kim,
R.S.Annan,
and
W.T.Miller
(2002).
Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.
|
| |
J Biol Chem,
277,
28238-28246.
|
 |
|
|
|
|
 |
M.T.Chou,
J.Wang,
and
D.J.Fujita
(2002).
Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
|
| |
BMC Biochem,
3,
32.
|
 |
|
|
|
|
 |
R.A.Engh,
and
D.Bossemeyer
(2002).
Structural aspects of protein kinase control-role of conformational flexibility.
|
| |
Pharmacol Ther,
93,
99.
|
 |
|
|
|
|
 |
S.E.Pursglove,
T.D.Mulhern,
J.P.Mackay,
M.G.Hinds,
and
G.W.Booker
(2002).
The solution structure and intramolecular associations of the Tec kinase SRC homology 3 domain.
|
| |
J Biol Chem,
277,
755-762.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Schreiner,
A.P.Schiavone,
and
T.E.Smithgall
(2002).
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
|
| |
J Biol Chem,
277,
45680-45687.
|
 |
|
|
|
|
 |
T.S.Ulmer,
J.M.Werner,
and
I.D.Campbell
(2002).
SH3-SH2 domain orientation in Src kinases: NMR studies of Fyn.
|
| |
Structure,
10,
901-911.
|
 |
|
|
|
|
 |
W.A.Lim
(2002).
The modular logic of signaling proteins: building allosteric switches from simple binding domains.
|
| |
Curr Opin Struct Biol,
12,
61-68.
|
 |
|
|
|
|
 |
D.Wang,
X.Y.Huang,
and
P.A.Cole
(2001).
Molecular determinants for Csk-catalyzed tyrosine phosphorylation of the Src tail.
|
| |
Biochemistry,
40,
2004-2010.
|
 |
|
|
|
|
 |
H.Zhang,
and
K.A.Gallo
(2001).
Autoinhibition of mixed lineage kinase 3 through its Src homology 3 domain.
|
| |
J Biol Chem,
276,
45598-45603.
|
 |
|
|
|
|
 |
J.Shaffer,
G.Sun,
and
J.A.Adams
(2001).
Nucleotide release and associated conformational changes regulate function in the COOH-terminal Src kinase, Csk.
|
| |
Biochemistry,
40,
11149-11155.
|
 |
|
|
|
|
 |
M.A.Young,
S.Gonfloni,
G.Superti-Furga,
B.Roux,
and
J.Kuriyan
(2001).
Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
|
| |
Cell,
105,
115-126.
|
 |
|
|
|
|
 |
M.Miller,
K.Ginalski,
B.Lesyng,
N.Nakaigawa,
L.Schmidt,
and
B.Zbar
(2001).
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies.
|
| |
Proteins,
44,
32-43.
|
 |
|
|
|
|
 |
N.V.Prabhu,
S.A.Siddiqui,
J.S.McMurray,
and
B.M.Pettitt
(2001).
Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
|
| |
Biopolymers,
59,
167-179.
|
 |
|
|
|
|
 |
M.P.Scott,
and
W.T.Miller
(2000).
A peptide model system for processive phosphorylation by Src family kinases.
|
| |
Biochemistry,
39,
14531-14537.
|
 |
|
|
|
|
 |
M.Porter,
T.Schindler,
J.Kuriyan,
and
W.T.Miller
(2000).
Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
|
| |
J Biol Chem,
275,
2721-2726.
|
 |
|
|
|
|
 |
M.R.Burnham,
P.J.Bruce-Staskal,
M.T.Harte,
C.L.Weidow,
A.Ma,
S.A.Weed,
and
A.H.Bouton
(2000).
Regulation of c-SRC activity and function by the adapter protein CAS.
|
| |
Mol Cell Biol,
20,
5865-5878.
|
 |
|
|
|
|
 |
N.Isakov,
and
B.Biesinger
(2000).
Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products.
|
| |
Eur J Biochem,
267,
3413-3421.
|
 |
|
|
|
|
 |
S.D.Briggs,
E.C.Lerner,
and
T.E.Smithgall
(2000).
Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo.
|
| |
Biochemistry,
39,
489-495.
|
 |
|
|
|
|
 |
S.R.Hubbard,
and
J.H.Till
(2000).
Protein tyrosine kinase structure and function.
|
| |
Annu Rev Biochem,
69,
373-398.
|
 |
|
|
|
|
 |
Y.C.Ma,
J.Huang,
S.Ali,
W.Lowry,
and
X.Y.Huang
(2000).
Src tyrosine kinase is a novel direct effector of G proteins.
|
| |
Cell,
102,
635-646.
|
 |
|
|
|
|
 |
C.B.Post,
B.S.Gaul,
E.Z.Eisenmesser,
and
M.L.Schneider
(1999).
NMR structure of phospho-tyrosine signaling complexes.
|
| |
Med Res Rev,
19,
295-305.
|
 |
|
|
|
|
 |
C.S.Mason,
C.J.Springer,
R.G.Cooper,
G.Superti-Furga,
C.J.Marshall,
and
R.Marais
(1999).
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.
|
| |
EMBO J,
18,
2137-2148.
|
 |
|
|
|
|
 |
D.A.Hartley,
T.R.Hurley,
J.S.Hardwick,
T.C.Lund,
P.G.Medveczky,
and
B.M.Sefton
(1999).
Activation of the lck tyrosine-protein kinase by the binding of the tip protein of herpesvirus saimiri in the absence of regulatory tyrosine phosphorylation.
|
| |
J Biol Chem,
274,
20056-20059.
|
 |
|
|
|
|
 |
F.W.Herberg,
M.L.Doyle,
S.Cox,
and
S.S.Taylor
(1999).
Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase.
|
| |
Biochemistry,
38,
6352-6360.
|
 |
|
|
|
|
 |
H.Cheng,
J.A.Rogers,
N.A.Dunham,
and
T.E.Smithgall
(1999).
Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.
|
| |
Mol Cell Biol,
19,
8335-8343.
|
 |
|
|
|
|
 |
J.C.Whisstock,
and
A.M.Lesk
(1999).
SH3 domains in prokaryotes.
|
| |
Trends Biochem Sci,
24,
132-133.
|
 |
|
|
|
|
 |
J.M.Sowadski,
L.F.Epstein,
L.Lankiewicz,
and
R.Karlsson
(1999).
Conformational diversity of catalytic cores of protein kinases.
|
| |
Pharmacol Ther,
82,
157-164.
|
 |
|
|
|
|
 |
Q.Xu,
J.Zheng,
R.Xu,
G.Barany,
and
D.Cowburn
(1999).
Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of abelson.
|
| |
Biochemistry,
38,
3491-3497.
|
 |
|
|
|
|
 |
S.D.Briggs,
and
T.E.Smithgall
(1999).
SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts.
|
| |
J Biol Chem,
274,
26579-26583.
|
 |
|
|
|
|
 |
T.Schindler,
F.Sicheri,
A.Pico,
A.Gazit,
A.Levitzki,
and
J.Kuriyan
(1999).
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.
|
| |
Mol Cell,
3,
639-648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Xu,
A.Doshi,
M.Lei,
M.J.Eck,
and
S.C.Harrison
(1999).
Crystal structures of c-Src reveal features of its autoinhibitory mechanism.
|
| |
Mol Cell,
3,
629-638.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Zhu,
J.L.Kim,
J.R.Newcomb,
P.E.Rose,
D.R.Stover,
L.M.Toledo,
H.Zhao,
and
K.A.Morgenstern
(1999).
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.
|
| |
Structure,
7,
651-661.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Barilá,
and
G.Superti-Furga
(1998).
An intramolecular SH3-domain interaction regulates c-Abl activity.
|
| |
Nat Genet,
18,
280-282.
|
 |
|
|
|
|
 |
J.C.Williams,
R.K.Wierenga,
and
M.Saraste
(1998).
Insights into Src kinase functions: structural comparisons.
|
| |
Trends Biochem Sci,
23,
179-184.
|
 |
|
|
|
|
 |
M.LaFevre-Bernt,
F.Sicheri,
A.Pico,
M.Porter,
J.Kuriyan,
and
W.T.Miller
(1998).
Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
|
| |
J Biol Chem,
273,
32129-32134.
|
 |
|
|
|
|
 |
P.Hof,
S.Pluskey,
S.Dhe-Paganon,
M.J.Eck,
and
S.E.Shoelson
(1998).
Crystal structure of the tyrosine phosphatase SHP-2.
|
| |
Cell,
92,
441-450.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Lock,
C.L.Abram,
T.Gibson,
and
S.A.Courtneidge
(1998).
A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate.
|
| |
EMBO J,
17,
4346-4357.
|
 |
|
|
|
|
 |
S.R.Hubbard,
M.Mohammadi,
and
J.Schlessinger
(1998).
Autoregulatory mechanisms in protein-tyrosine kinases.
|
| |
J Biol Chem,
273,
11987-11990.
|
 |
|
|
|
|
 |
F.Sicheri,
and
J.Kuriyan
(1997).
Structures of Src-family tyrosine kinases.
|
| |
Curr Opin Struct Biol,
7,
777-785.
|
 |
|
|
|
|
 |
S.Gonfloni,
J.C.Williams,
K.Hattula,
A.Weijland,
R.K.Wierenga,
and
G.Superti-Furga
(1997).
The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
|
| |
EMBO J,
16,
7261-7271.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |